A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab

Clinical trial NCT04998851 · COMPLETED

Trial details

NCT number: NCT04998851
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis Clinically Isolated Syndrome

Start date: 2021-09-16
Primary completion: 2024-03-29
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.